Study on the Safety of Neladenoson Bialanate, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Dug Given as a Single Oral Dose in Participants With Liver Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Clinical trial NCT04322253 · TERMINATED

Trial details

NCT number

NCT04322253

Sponsor

Bayer

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-08-24

Primary completion

2018-08-22

Enrollment

22

View on ClinicalTrials.gov